The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
PK11195 labels activated microglia in Alzheimer's disease and in vivo in a mouse model using PET
Open accessAbstract
Activated microglia may promote neurodegeneration in Alzheimer's disease (AD) and may also help in amyloid clearance in immunization therapies. In vivo imaging of activated microglia using positron emission tomography (PET) could assist in defining the role of activated microglia during AD progression and therapeutics. We hypothesized that PK11195, a ligand that binds activated microglia, could label these cells in postmortem AD tissues and in vivo in an animal model of AD using PET. [(3)H](R)-PK11195 binding was significantly higher in AD frontal cortex compared to controls and correlated mainly with the abundance of immunohistochemically labeled activated microglia. With age, the brains of APP/PS1 transgenic mice showed progressive increase in [(3)H](R)-PK11195 binding and [(11)C](R)-PK11195 retention in vivo assessed using microPET, which correlated with the histopathological abundance of activated microglia. These results suggest that PK11195 binding in AD postmortem tissue and transgenic mice in vivo correlates with the extent of microglial activation and may help define the role of activated microglia in the pathogenesis and treatment of AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“It is generally accepted that microglia and macrophages are the primary cell types exhibiting an increased number of TSPO binding sites in human pathologies, and that astrocytes are not significant contributors to increased TSPO binding sites [44;45].”
From Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain (2009) · cites this paper as [44]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glutamate neurotoxicity and diseases of the nervous system
Choi, D. W. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 8,188
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Bard, F., Cannon, C., Barbour, R., Burke, R.-L., Games, D., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., et al. (2000) · Nature Medicine · doi:10.1038/78682 · Cited by 2,012
Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report
Nicoll, J. A. R., Wilkinson, D., Holmes, C., Steart, P., Markham, H., & Weller, R. O. (2003) · Nature Medicine · doi:10.1038/nm840 · Cited by 1,397
Simard, A. R., Soulet, D., Gowing, G., Julien, J.-P., & Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.022 · Cited by 1,265
Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease
Smith, M. A., Richey Harris, P. L., Sayre, L. M., Beckman, J. S., & Perry, G. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02653.1997 · Cited by 1,239
Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease
in 't Veld, B. A., Ruitenberg, A., Hofman, A., Launer, L. J., van Duijn, C. M., Stijnen, T., Breteler, M. M. B., & Stricker, B. H. C. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010178 · Cited by 1,196
Risk of Alzheimer's disease and duration of NSAID use
Stewart, W. F., Kawas, C., Corrada, M., & Metter, E. J. (1997) · Neurology · doi:10.1212/wnl.48.3.626 · Cited by 1,132
In-vivo measurement of activated microglia in dementia
Cagnin, A., Brooks, D. J., Kennedy, A. M., Gunn, R. N., Myers, R., Turkheimer, F. E., Jones, T., & Banati, R. B. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05625-2 · Cited by 1,054
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–138 of 138
PET imaging in animal models of Parkinson’s disease
Ni, R. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.114174 · Cited by 12
Fairley, L. H., Lai, K. O., Grimm, A., Eckert, A., & Barron, A. M. (2024) · Biochimie · doi:10.1016/j.biochi.2024.07.003 · Cited by 14
Visigalli, I., Moresco, R. M., Belloli, S., Politi, L. S., Gritti, A., Ungaro, D., Matarrese, M., Turolla, E. A., Falini, A., Scotti, G., et al. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.12.019 · Cited by 12
Role of neuroimaging in drug development
Medhi, B., Misra, S., Avti, P., Kumar, P., Kumar, H., & Singh, B. (2014) · Reviews in the Neurosciences · doi:10.1515/revneuro-2014-0031 · Cited by 10
PET Imaging of Neuroinflammation
Chaney, A. M., Deal, E. M., Jackson, I. M., & James, M. L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-816386-3.00047-8 · Cited by 9
Imaging of Microglial Activation in Alzheimer’s Disease by [11C]PBR28 PET
Donat, C. K., Mirzaei, N., Tang, S.-P., Edison, P., & Sastre, M. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7704-8_22 · Cited by 8
Zatcepin, A., Heindl, S., Schillinger, U., Kaiser, L., Lindner, S., Bartenstein, P., Kopczak, A., Liesz, A., Brendel, M., & Ziegler, S. I. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.830020 · Cited by 6
Butt, C. M., Harrison, J., Rowe, R. K., Jones, J. R., Wynalda, K., Salem, N., Lifshitz, J., & Pauly, J. (2017) · Current Research Concussion · doi:10.1055/s-0037-1606836 · Cited by 5
Kara, F., Neyal, N., Kamykowski, M. G., Schwarz, C. G., Kendall‐Thomas, J., Morrison, H. A., Senjem, M. L., Przybelski, S. A., Fought, A. J., Port, J. D., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178656 · Cited by 5
Chow, C. Y., & King, G. F. (2024) · Toxins · doi:10.3390/toxins16070307 · Cited by 5
Lindgrén, N., Tuisku, J., Vuoksimaa, E., Helin, S., Karrasch, M., Marjamäki, P., Kaprio, J. A., & Rinne, J. O. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa024 · Cited by 6
Imaging in Neurology Research II: PET Imaging of CNS Disorders
Henriksen, G., & Drzezga, A. E. (2010) · Springer eBooks · doi:10.1007/978-3-642-12945-2_33 · Cited by 5
Gargiulo, S., Coda, A. R. D., Panico, M., Gramanzini, M., Moresco, R. M., Chalon, S., & Pappatà, S. (2017) · The Quarterly Journal of Nuclear Medicine and Molecular Imaging · doi:10.23736/s1824-4785.16.02948-4 · Cited by 6
Kong, Y., Maschio, C., Shi, X., Yao, B., Xie, F., Zuo, C., Konietzko, U., Shi, K., Rominger, A., Xiao, J., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.21.554163 · Cited by 4
Positron Emission Tomography in Animal Models of Alzheimer’s Disease AmyloidosisPreprint
Ni, R. (2021) · Preprints.org · doi:10.20944/preprints202110.0222.v1 · Cited by 2
McLeod, R. E., Kale, K. M., Weglinski, C., Masoud, A. M., Akbar, N., Probert, F., Anthony, D. C., & Zainal, J. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.07.027 · Cited by 2
Neuroinflammation in Alzheimer's Disease
(2020) · Case Medical Research · doi:10.31525/ct1-nct04274998 · Cited by 2
Neuroinflammation in Neurological Dysfunction and Degeneration
Chen, S., Oyarzabal, E. A., Santos, J. H., Wang, Q., Jiang, L., & Hong, J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800228-5.00018-2 · Cited by 2
Ni, R. (2015) · Figshare · Cited by 2
Immunoinflammatory Mechanisms in Sex-Dependent Vulnerability to Neuropsychiatric Disorders
Macêdo, D. S., Torres, D., Gomes, N. S., Soares, M. V. R., Lós, D. B., & Fiorenza, N. G. (2024) · Integrated science · doi:10.1007/978-3-031-72079-6_4 · Cited by 1
Alfaifi, B., Tuisku, J., Matilainen, M., Anton-Rodriguez, J., Lewis, D., Jackson, A., Coope, D., Airas, L., Deakin, B., Herholz, K., et al. (2025) · Journal of Cerebral Blood Flow and Metabolism · doi:10.1177/0271678x251348790 · Cited by 1
Woodcock, T. (2010) · UKnowledge (University of Kentucky) · Cited by 1
The Role of Adaptive and Innate Immunity in Alzheimer’s Disease
Holmes, C. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108539623.012 · Cited by 1
Review Article Alzheimer's disease biomarkers in animal models: closing the translational gap
Sabbagh, J. J., Kinney, J. W., Cummings, J. L., & Ruvo, L. (2013)
The translocator protein as a drug target in Alzheimer's
Chua, S. W., Kassiou, M., & Ittner, L. M. (2014)
Linking Molecular Neurobiology to Therapeutic Approaches for Alzheimer’s Disease with PET
Luiten, P. G. M., Masman, M. F., Dobos, N., Nyakas, C. J., de Vries, E. F. J., Dierckx, R., & Eisel, U. L. M. (2014) · Springer eBooks · doi:10.1007/978-3-642-54307-4_20
Giannetti, P. (2015) · Spiral (Imperial College London) · doi:10.25560/34680
Huang, Y. H., Jia, H., & Bao, W. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816475-4.00013-6
Radiopharmaceuticals in Pediatric Nuclear Medicine
Snyder, S. E., Butch, E. R., & Shulkin, B. L. (2020) · Wiley eBooks · doi:10.1002/9781119500575.ch21
Molecular Imaging Biomarkers and Agents
Shaikh, S. (2022) · Springer eBooks · doi:10.1007/978-981-16-9535-3_3
Faculty Opinions recommendation of Neuroinflammation in Alzheimer's disease.
Perani, D. (2017) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.725413893.793537457
APOE ε4 gene dose effect on imaging and blood biomarkers of glial reactivity and β-amyloid pathologyPreprint
Snellman, A., Ekblad, L. L., Tuisku, J., Koivumäki, M., Ashton, N. J., Lantero‐Rodriguez, J., Karikari, T. K., Helin, S., Bucci, M., Löyttyniemi, E., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.19.508484
Dietrich, K. (2015) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-4863
Snellman, A., Ekblad, L. L., Tuisku, J., Koivumäki, M., Ashton, N. J., Lantero‐Rodriguez, J., Karikari, T. K., Helin, S., Bucci, M., Löyttyniemi, E., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22620676
Metadata
- Authors
- Venneti, S., Lopresti, B. J., Wang, G., Hamilton, R. L., Mathis, C. A., Klunk, W. E., Apte, U. M., & Wiley, C. A.
- Affiliations
- University of Pittsburgh (US)
- Corresponding author
- Wiley, Clayton A.
- ORCID
- Venue
- Neurobiology of Aging
- Publisher
- Elsevier BV
- Published
- 2009-08
- Volume
- 30
- Issue
- 8
- Pages
- 1217-1226
- ISSN
- 0197-4580 (ISSN-L)
- PMC
- PMC2745919
- OpenAlex
- W2011239875
- Cited by
- 138
- References
- 39
- Citations by year
- 2025: 3 · 2024: 6 · 2023: 3 · 2022: 8 · 2021: 9 · 2020: 11 · 2019: 9 · 2018: 9 · 2017: 11 · 2016: 8 · 2015: 10 · 2014: 13 · 2013: 7 · 2012: 13
- FWCI
- 3.96
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Neurobiology of Aging (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- University of Pittsburgh
- National Institutes of Health
- National Institute on Aging (R21AG025829, P50AG005133, R01AG020226, P50 AG05133-21)
- National Institute of Mental Health (R01 MH-64921, K24 MH01717, R01MH064921, K24MH001717, R01MH071151)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- PK11195, activated microglia, Alzheimer's disease, positron emission tomography, APP/PS1 mice, microglial activation, amyloid clearance, neurodegeneration, frontal cortex, radioligand binding, in vivo imaging
- MeSH terms
- Aged, Aged, 80 and over, Aging, Alzheimer Disease, Animals, Astrocytes, Brain, Disease Models, Animal, Female, Frontal Lobe, Humans, Isoquinolines, Male, Mice, Transgenic, Receptors, Cell Surface, Tritium, Amyloid beta-Protein Precursor, Microglia, Disease Progression, Positron-Emission Tomography, Mice, Presenilin-1, Protease Nexins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
